En vivo
Endpoints NewsMigraine biotech Vedana Therapeutics makes its debut with $46M Series ABioPharma DiveA new Westlake-backed biotech takes aim at migraines10x Genomics NewsTXG (Nasdaq) RSU vesting entries listed on Form 144 with JP Morgan intermediary - Stock TitanClinical OMICsCancer Diagnostics: Droplet Digital PCR Testing for HPV+ Cancer in the ClinicEndpoints NewsHealth groups say HHS is trying to 'rush reinstatement' of ACIPEndpoints NewsB cell therapy maker Be Bio stops hemophilia trialClinical OMICsFibroblast Signaling Pathways Linked to Angiogenesis Differences in NSCLCEndpoints NewsFDA raises no major red flags with Moderna's flu shotFierceBiotechEli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4EFierceBiotechAmenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grillingThermo FisherThermo Fisher Expands Orbitrap Platform Across Research, Biopharma and Environmental Testing at ASMS 2026 - Lab ManagerClinical OMICsMini Brains Help Identify Treatment for Rare Form Parkinson’s Disease

Archivo

Reciente Más antiguo Borrar
@MACHEREY-NAGEL GmbH & Co. KG
Total 26
Fuente MACHEREY-NAGEL GmbH & Co. KG
Búsqueda --